Argentinian packaging provider, Envases Group, has acquired a Nilpeter FA-22 multi-substrate press to further build on its provision of pharmaceutical packaging in the South American region.
The FA-Line is the a versatile flexo press designed with an intuitive user-interface and fully mobile print controls. The modular, multi-substrate FA-22 provides a stability and a high register tolerance on multiple substrates.
‘This jump in technology, versus the flexo and gravure solvent based machines currently used in the Argentinian market, alongside the acquisitions of the new Nilpeter FA-22 will allow us to offer our customers the latest alternatives in printing quality, but also the safest, as they are nitro free,’ said Ignacio Siccardi, head of pharmaceutical division, Envases Group.’
‘Lately, in the pharma world, there have been some repercussions about how nitro-based primers and inks react to the temperature in the blister machine lines, and produce nitrosamines which is a compound that causes cancer in humans. That’s why UV LED and nitro-free inks are the future of printing in pharma,’ Mr Siccardi continued. ‘Our idea and ambition with this investment is to back our customers with their new high velocity blister lines, and offer them a safe, excellent quality and quick lead times to better meet their needs, in either flexo or digital, and in any design’.
Envases Group has plants in Buenos Aires, San Luis and in Cartagena, Colombia, and specializes in aerosol aluminium and tinplate cans. Last year, the company launched a new pharmaceutical packaging division with the acquisition of the only roll-to-roll Hapa digital printer in Latin America.
